EQS-Adhoc: MeVis Medical Solutions AG: Anpassung der Prognose für das laufende Geschäftsjahr
|
EQS-Ad-hoc: MeVis Medical Solutions AG / Schlagwort(e): Prognoseänderung Bremen, 4. September 2024 – Die MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], ein führendes Softwareunternehmen der bildbasierten Medizin, passt basierend auf den vorläufigen Geschäftszahlen der ersten elf Monate ihre Jahresprognose für das laufende Geschäftsjahr an.
Gründe für den Umsatzrückgang sind eine unerwartete Zurückhaltung im Kaufverhalten aufgrund von weltweiten ökonomischen Herausforderungen. Außerdem wird das Ergebnis stark durch die Wechselkursentwicklung US Dollar zu Euro seit Beginn des Geschäftsjahres belastet. ************************************************************************ Kontakt: Kirchhoff, Marcus / CEO Ende der Insiderinformation
04.09.2024 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. |
| Sprache: | Deutsch |
| Unternehmen: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Deutschland | |
| Telefon: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-Mail: | ir@mevis.de |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Börsen: | Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1981763 |
| Ende der Mitteilung | EQS News-Service |
|
|
1981763 04.09.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 16,76 | 18,07 | 17,13 | 16,21 | 18,76 | 17,34 | 18,30 | |
| EBITDA1,2 | 7,60 | 8,25 | 5,97 | 4,77 | 7,99 | 3,99 | 4,91 | |
| EBITDA-Margin3 | 45,35 | 45,66 | 34,85 | 29,43 | 42,59 | 23,01 | 26,83 | |
| EBIT1,4 | 6,69 | 8,00 | 5,81 | 4,64 | 7,90 | 3,89 | 4,80 | |
| EBIT-Margin5 | 39,92 | 44,27 | 33,92 | 28,62 | 42,11 | 22,43 | 26,23 | |
| Net Profit (Loss)1 | 7,17 | 8,07 | 5,70 | 4,55 | 7,79 | 4,92 | 5,70 | |
| Net-Margin6 | 42,78 | 44,66 | 33,28 | 28,07 | 41,53 | 28,37 | 31,15 | |
| Cashflow1,7 | 5,52 | 6,55 | 2,89 | 9,13 | 4,86 | 5,85 | 0,00 | |
| Earnings per share8 | 3,94 | 4,43 | 3,13 | 2,50 | 4,28 | 2,70 | 3,15 | |
| Dividend per share8 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Deloitte
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| MeVis Med. Solutions | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0LBFE | DE000A0LBFE4 | AG | 44,41 Mio € | 16.11.2007 | Halten | 9F5C4V35+HX |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 10,17 | 10,24 | 0,99 | 7,43 | 2,49 | 7,59 | 2,56 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,95 | 0,95 | 0,95 | 3,89% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 19.03.2024 | - | 27.05.2025 | - | 30.01.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,25% | -2,36% | -3,17% | -3,17% | -55,64% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
